×

Viatar CTC Solutions Announces Participation in Upcoming Conferences

LOWELL, Mass., May 21, 2015 (GLOBE NEWSWIRE) -- Viatar CTC Solutions Inc. (OTC Pink:VRTT), a medical technology company focused on the treatment of patients with metastatic cancer, today announced that its Chairman and CEO, Ilan Reich, will provide a corporate overview during presentations at the following upcoming investor conferences.

Event: SeeThruEquity 4th Annual Microcap Investor Conference
Date: May 28, 2015
Time: 9:30-10:00AM ET
Location: Convene Grand Central, 101 Park Avenue, New York City
Event: 2015 Marcum MicroCap Conference
Date: May 28, 2015
Time: 3:00-3:30PM ET
Location: Grand Hyatt Hotel, 109 E 42nd St, New York City

About Viatar CTC Solutions Inc.

Viatar CTC Solutions Inc. is a medical technology company focused on the treatment of patients with metastatic cancer. The company's lead product, the ViatarTM Therapeutic Oncopheresis System, removes circulating tumor cells from whole blood using label-free cross-flow filtration. Pending regulatory approval targeted for 2016, it will be used as a periodic therapy to improve overall survival for a wide range of solid tumor types such as lung, breast, colon, prostate and gastric cancers.

This proprietary technology also powers the company's liquid biopsy products, which are collection systems for use by genetic testing companies, researchers and medical oncologists that provide a greater quantity and purity of circulating tumor cells for their molecular analysis and personalized medicine objectives.

CONTACT: Investor Contact: David Burke The Ruth Group 646-536-7009 dburke@theruthgroup.comSource:Viatar CTC Solutions Inc.